Our findings showed that CD4+ Tregs were more abundant in tumor samples and metastatic lymph nodes than in adjacent tissues and normal lymph nodes, implying the potential role of CD4+ Tregs in facilitating lymph node metastasis in ESCC (Supplementary Fig. S4c). This evidence concerns the gene CD4 and neoplasm.